Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Amortization - Goodwill Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Catheter Precision (VTAK) Shares Issued (2017 - 2025)

Catheter Precision has reported Shares Issued over the past 8 years, most recently at -$3.7 million for Q4 2025.

Quarterly Shares Issued fell 415.95% to -$3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$385000.0 through Dec 2025, down 104.9% year-over-year, with the annual reading at $1.2 million for FY2024, 85.19% down from the prior year.
Shares Issued was -$3.7 million for Q4 2025 at Catheter Precision, down from $2.2 million in the prior quarter.
Over five years, Shares Issued peaked at $10.6 million in Q2 2021 and troughed at -$3.7 million in Q4 2025.
The 5-year median for Shares Issued is $792500.0 (2022), against an average of $1.9 million.
Year-over-year, Shares Issued surged 5204.0% in 2023 and then crashed 415.95% in 2025.
A 5-year view of Shares Issued shows it stood at $48000.0 in 2021, then soared by 733.33% to $400000.0 in 2022, then skyrocketed by 1568.5% to $6.7 million in 2023, then plummeted by 82.24% to $1.2 million in 2024, then crashed by 415.95% to -$3.7 million in 2025.
Per Business Quant, the three most recent readings for VTAK's Shares Issued are -$3.7 million (Q4 2025), $2.2 million (Q3 2025), and $1.2 million (Q4 2024).